Women who use hormone therapy after menopause may be at a higher risk of ovarian cancer, and the risk remains elevated for up to two years after women stop taking estrogen, a new study says. What’s more, even a relatively short duration of hormone therapy — less than four years — is associated with a 30 to 40 percent higher risk of ovarian cancer in current users, according to the study, which was published Wednesday in the Journal of the American Medical Association. However, experts say this may not be as scary as it sounds
